Ensign Peak Advisors
GH icon

Ensign Peak Advisors’s Guardant Health GH Stock Holding History

Ensign Peak Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.76M Sell
38,407
-17,804
-32% -$1.94M 0.01% 542
2026
Q1 		$5.19M Buy
56,211
+8,249
+17% +$828K 0.01% 525
2025
Q4 		$4.9M Sell
47,962
-192,461
-80% -$17.2M 0.01% 526
2025
Q3 		$15M Buy
240,423
+196,998
+454% +$10.7M 0.02% 371
2025
Q2 		$2.26M Buy
43,425
+1,975
+5% +$88.2K ﹤0.01% 859
2025
Q1 		$1.77M Hold
41,450
– – ﹤0.01% 950
2024
Q4 		$1.27M Hold
41,450
– – ﹤0.01% 1170
2024
Q3 		$951K Hold
41,450
– – ﹤0.01% 1351
2024
Q2 		$1.2M Buy
41,450
+1,800
+5% +$41.9K ﹤0.01% 1171
2024
Q1 		$818K Sell
39,650
-2,000
-5% -$42.9K ﹤0.01% 1443
2023
Q4 		$1.13M Buy
41,650
+6,250
+18% +$164K ﹤0.01% 1282
2023
Q3 		$1.05M Hold
35,400
– – ﹤0.01% 1169
2023
Q2 		$1.27M Buy
35,400
+3,050
+9% +$87.6K ﹤0.01% 1080
2023
Q1 		$758K Buy
32,350
+3,000
+10% +$85.7K ﹤0.01% 1457
2022
Q4 		$798K Buy
29,350
+7,050
+32% +$323K ﹤0.01% 1345
2022
Q3 		$1.2M Sell
22,300
-289,924
-93% -$14.9M ﹤0.01% 975
2022
Q2 		$12.6M Buy
312,224
+140
+0% +$6.94K 0.03% 340
2022
Q1 		$20.7M Buy
312,084
+291,204
+1,395% +$19.9M 0.04% 292
2021
Q4 		$2.09M Buy
+20,880
New +$2.16M ﹤0.01% 935
2021
Q1 		– Sell
-2,619
Closed -$338K – 1848
2020
Q4 		$338K Hold
2,619
– – ﹤0.01% 1659
2020
Q3 		$293K Buy
+2,619
New +$240K ﹤0.01% 1622

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Ensign Peak Advisors's GH Position: Q2 2026 in Review

Ensign Peak Advisors reduced its Guardant Health (GH) stake by 32% in Q2 2026, selling an estimated $1.94M and leaving 38,407 shares worth $5.76M. The position accounts for 0.01% of the portfolio, ranked #542.

Ensign Peak Advisors first reported a position in GH in Q3 2020 and has held it in 21 quarters since. The position peaked at $20.7M in Q1 2022. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Ensign Peak Advisors held 38,407 shares of Guardant Health worth $5.76M as of Q2 2026.
  • Ensign Peak Advisors sold 17,804 Guardant Health shares in Q2 2026, an estimated $1.94M.
  • Guardant Health made up 0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #542 holding.
  • Ensign Peak Advisors first reported a position in Guardant Health in Q3 2020 and has held it in 21 quarters since.
  • Ensign Peak Advisors's Guardant Health position peaked at $20.7M in Q1 2022.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.